Schedule 13D ownership disclosure
HUMACYTE INC
Security class unavailable · CUSIP: 44486Q103
Event date: 2024-11-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,007,745
- Percent of class
- 4.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001818382-24-000210
- Form type
- SC 13D
- Filer
- Humacyte, Inc.
- CIK
- CIK 1818382
- Filed
- Nov 20, 2024
- Reporting period
- Nov 18, 2024
- Description
- Schedule 13D beneficial ownership